News

VIVEbiotech Launches Lentiviral Vectors Mfg. Plant

Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.

Base Editor Corrects Sickle-Cell Disease Mutation, Achieves Phenotypic Rescue in Mice

An adenine base editor was used to convert the sickle-cell disease (SCD) allele to a nonpathogenic allele in hematopoietic stem and…

DNA sequencing test maker Helix doubles down on COVID-19 testing, tracking with $50M series C

DNA sequencing test maker Helix doubles down on COVID-19 testing, tracking with $50M series C

Novartis reports 'clinically relevant' survival data for Lutathera

The radioligand therapy was linked with a significant increase in progression-free survival and a clinically relevant increase in overall survival in…

Jubilant HollisterStier Expands Sterile Injectable Mfg. Capacity

Investing $92 million at its site in Spokane, WA to add 50% capacity, which will be commercially operational by the end of 2024.

Gut Microbiome Linked to Breast Microbiome and Breast Cancer

Scientists at Wake Forest School of Medicine demonstrate that diet, including fish oil supplements, can not only alter the breast…

Organon launches ready to shop for women's health companies in biotech, medtech and more

Organon launches ready to shop for women's health companies in biotech, medtech and more

NICE turns down GSK's IV Benlysta for systemic lupus

The cost watchdog said uncertain trial evidence and cost-effectiveness estimates are behind the preliminary decision

CPL Completes Successful Virtual Health Canada Audit

The CDMO created a virtual tour of its facilities in response to the pandemic.

Synthetic E. Coli Reprogrammed to Make Polymers from Artificial Monomers, and Resist Viral Infections

Scientists at the MRC Laboratory of Molecular Biology developed a synthetic strain of E. coli that can construct artificial…

Chutes & Ladders—Repertoire Immune Medicines, buzzing from $189M series B, taps Celgene vet as CMO

Chutes & Ladders—Repertoire Immune Medicines, buzzing from $189M series B, taps Celgene vet as CMO

Lynparza shows promise in preventing cancer recurrence

Lynparza is the first medicine targeting BRCA mutations to show clinical benefit in adjuvant setting

PharmaBlock Sciences Partners with Shouyao Holdings

Will support CMC development and manufacturing of Shouyao’s second-generation ALK inhibitor for non-small cell lung cancer.

Studies on Immune Frenemies in the Brain Reveal Private Source in Local Bone Marrow

Researchers at Washington University School of Medicine in St. Louis have discovered that the immune cells in the protective tissue…

Synchron raises $40M to trial neurotech that helps paralysis patients text, email and shop online

Synchron raises $40M to trial neurotech that helps paralysis patients text, email and shop online

What’s next for patient advocacy?

Virtual event from OVID and the Patient Partnership Index is now open for registration

Biovectra Inc. Unveils New Logo and Brand

New image reflects the growing company’s full suite of expertise and core values.

Type 2 Diabetes Patients Can Benefit from Stem Cell Transplants

In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated…

China's Stemirna raises $188M to fund mRNA COVID-19 vaccine

China's Stemirna raises $188M to fund mRNA COVID-19 vaccine

'Indian' variant of coronavirus now dominant strain in the UK

Officials warned that early evidence suggests there may be an increased risk of hospitalisation for Delta compared to the Alpha (Kent) strain

Samsung Biologics Signs Agreement with Kahr Medical

Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.

Cytiva Acquires German Scientific Software Maker GoSilico

Cytiva officials claim the GoSilico acquisition will differentiate Cytiva as a premier partner in bioprocessing.

How new insights into skull-based immune cells could inspire treatments for brain disease

How new insights into skull-based immune cells could inspire treatments for brain disease

J&J’s Tremfya shows significant improvements for post-TNFi psoriatic arthritis patients

IL-23 inhibitor helped patients achieve complete skin clearance and joint symptom improvement

Onyx Scientific Receives Commercial API License for UK Facility

Allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture.

Spatial Biology: A New Dimension for Genomics

In this GEN Live episode, sponsored by 10x Genomics, we’re excited to have team leaders from young spatial companies join us to discuss…

Merck-partnered Janux hires CMO as its bispecifics near clinic

Merck-partnered Janux hires CMO as its bispecifics near clinic

Novartis’ CAR T therapy Kymriah shows promise in follicular lymphoma

Kymriah led to responses for the majority of treated patients, with 66% achieving a complete response (CR)

Alliance to Zero Founded for ‘Green’ Pharma Supply Chain Initiative

Goal is to help pharma sector comply with net-zero emissions in line with the Paris Climate Agreement.

COVID-19 Antiviral Candidate Hobbles RNA Replicase

An RNA replicase essential to the replication of SARS-CoV-2 depends on iron-sulfur clusters located in a catalytic subunit. The clusters…

ASCO: Amgen's stomach cancer drug, nabbed in Five Prime buyout, extends patients' lives in phase 2

ASCO: Amgen's stomach cancer drug, nabbed in Five Prime buyout, extends patients' lives in phase 2

Opdivo, Yervoy combination approved to treat malignant pleural mesothelioma

Combination immunotherapy treatment approved in the EU for first-line treatment of adults with unresectable MPM

Selkirk Pharma Begins Construction of Injectable Mfg. Facility in Spokane

New fill and finish facility will add critically needed capacity for the manufacture of commercial and clinical trial drugs.

Solve Your Biotherapeutic Challenges with Help from Gene Therapy University

The cell and gene therapy fields have exploded with new treatments for a variety of diseases, as well as the potential to treat a host of…

Sanofi inks partners for phase 3 pivotal trial of add-on breast cancer therapy

Sanofi inks partners for phase 3 pivotal trial of add-on breast cancer therapy

NICE draft guidance does not recommend Evrysdi for SMA

NICE said it is 'unable' to recommend the oral treatment due to high cost-effectiveness estimates

Moderna, Thermo Fisher Enter COVID Vax Fill/Finish Mfg. Pact

Thermo will provide aseptic fill/finish, labeling and packaging from its commercial manufacturing site in Greenville, NC.

Researchers Uncover Protein That Helps Tumors Evade Immune System

A new mouse study by researchers at the Francis Crick Institute demonstrates a potential new immunotherapy target. The researchers…

ASCO: Novartis backs up $2.1B Endocyte buyout with prostate cancer data

ASCO: Novartis backs up $2.1B Endocyte buyout with prostate cancer data

The 2021 Sales Awards welcomes new and returning categories

The Sales Awards have introduced a brand-new category alongside a few returning classics from previous years.




Contact Us